Mrs. Juan Zhang, People's Republic of China
Human mesenchymal-stem-cells derived exosomes play important roles in enhancing CB-treg suvival and functional stability

Björn Nashan, Germany
Phase 2 study design evaluating efficacy, safety, pharmacokinetics and pharmacodynamics of the anti-CD40 monoclonal antibody CFZ533 (iscalimab) in de novo liver transplant recipients: The CONTRAIL I study

Dr. Yeqi Nian, People's Republic of China
Targeting CD4+ T cell metabolism provides an effective and age-specific immunosuppression

Joseph R. Leventhal, United States
Long-term follow-up of a phase 2 clinical trial to induce tolerance in living donor renal transplant recipients